Nektar Therapeutics NKTR
Day Range
The total range of the associated security's price quotes as of market open.
The left value is the lowest price and right value is the highest price reported.
The arrow represents the current price quote (delayed by 15 minutes).
52-Week Range
The total range of the associated security's price quotes for the past 52 week period.
The left value is the lowest price and right value is the highest price reported (delayed by 15 minutes).
Average Price Target
A price target is an analyst's prediction of the future price of a security, often times looking out between 12 and 18 months.
The average price target represents the mean of the price targets provided by sell-side analysts.
All price targets are sourced from Benzinga's aggregated analyst data and are not provided by TradeStation.
Analyst Rating Score
The percentage of analysts who are rating this symbol as a buy.
The Analyst score is an aggregation of the available sell-side analyst ratings (provided by Benzinga).
Ratings from analysts are taken from the last rating available to be sourced and are calculated as follows:
- Sell: "sell",
- Neutral: "neutral",
- Buy: "buy",
- Hold: "neutral",
- Outperform: "buy",
- Underperform: "sell",
- Overweight: "buy",
- Equal-Weight: "neutral"
All ratings classes are provided by Benzinga and aggregated by TradeStation.
Next Earnings Call
The next upcoming earnings call date for the company. These are subject to change due to a number of reasons but are provided as the best of date according to current knowledge.
Provided by Benzinga.
Why is Nektar Therapeutics moving?
Why is Nektar Therapeutics moving?
This is provided by Benzinga, and is indicative of the reason that the relevant security is potentially moving in any direction. These are updated on a rolling basis by Benzinga.
Nektar Therapeutics Key Stats Summary
Volume
The number of shares traded since the latest market open for this security.
Average Volume
The average daily number of shares traded in the past month.
Market Cap
The total value of a security's shares, calculated by multiplying the total number of shares by the current price. This is generally considered an indicator of the overall size of a company.
P/E (TTM)
The Price to Earnings ratio is generally considered an indicator of the value of a security (whether it is over or undervalued). This is calculated by dividing the current price quote by the Earnings per Share.
EPS (TTM)
Earnings per share is generally thought to be indicative of the company's profitability. It shows how much a company is earning per all outstanding share. It is calculated by dividing the company's profit by the total number of shares outstanding.
Shares Outstanding
The total number of shares available for this security.
NKTR News Disclaimer
All news is provided by Benzinga and is written entirely by Benzinga authors.
Any articles are presented as they were provided by Benzinga, and do not represent the opinions of TradeStation or its employees.
Disclaimer
All news is provided by Benzinga and is written entirely by Benzinga authors.
Any articles are presented as they were provided by Benzinga, and do not represent the opinions of TradeStation or its employees.
The latest stories about Nektar Therapeutics
Earnings Calendar
About Nektar Therapeutics
Nektar Therapeutics Key Stats Summary
Volume
The number of shares traded since the latest market open for this security.
Average Volume
The average daily number of shares traded in the past month.
Market Cap
The total value of a security's shares, calculated by multiplying the total number of shares by the current price. This is generally considered an indicator of the overall size of a company.
P/E (TTM)
The Price to Earnings ratio is generally considered an indicator of the value of a security (whether it is over or undervalued). This is calculated by dividing the current price quote by the Earnings per Share.
EPS (TTM)
Earnings per share is generally thought to be indicative of the company's profitability. It shows how much a company is earning per all outstanding share. It is calculated by dividing the company's profit by the total number of shares outstanding.
Shares Outstanding
The total number of shares available for this security.
NKTR News Disclaimer
All news is provided by Benzinga and is written entirely by Benzinga authors.
Any articles are presented as they were provided by Benzinga, and do not represent the opinions of TradeStation or its employees.
Disclaimer
All news is provided by Benzinga and is written entirely by Benzinga authors.
Any articles are presented as they were provided by Benzinga, and do not represent the opinions of TradeStation or its employees.
The latest stories about Nektar Therapeutics
About Nektar Therapeutics
Why is Nektar Therapeutics moving?
Why is Nektar Therapeutics moving?
This is provided by Benzinga, and is indicative of the reason that the relevant security is potentially moving in any direction. These are updated on a rolling basis by Benzinga.
Earnings Calendar
Why is Nektar Therapeutics moving?
Why is Nektar Therapeutics moving?
This is provided by Benzinga, and is indicative of the reason that the relevant security is potentially moving in any direction. These are updated on a rolling basis by Benzinga.
Earnings Calendar
Analyst Top Buys & SellsAnalyst Top Buys & Sells
An aggregated list of the top rated and lowest rated securities across a selection of analysts (provided by Benzinga).
Top Buys and Sells are the top 10 highest and lowest (respectively) aggregate ratings calculated as follows:
- Sell: "sell",
- Neutral: "neutral",
- Buy: "buy",
- Hold: "neutral",
- Outperform: "buy",
- Underperform: "sell",
- Overweight: "buy",
- Equal-Weight: "neutral"
All ratings classes are provided by Benzinga and aggregated by TradeStation.
Analyst Top Buys & Sells
An aggregated list of the top rated and lowest rated securities across a selection of analysts (provided by Benzinga).
Top Buys and Sells are the top 10 highest and lowest (respectively) aggregate ratings calculated as follows:
- Sell: "sell",
- Neutral: "neutral",
- Buy: "buy",
- Hold: "neutral",
- Outperform: "buy",
- Underperform: "sell",
- Overweight: "buy",
- Equal-Weight: "neutral"
All ratings classes are provided by Benzinga and aggregated by TradeStation.
Check out what sell-side analysts are calling Top Buys & Sells
Get Started Today
Choose how you invest and trade with a full suite of trading platforms and tools designed to help you claim your financial edge.
Market data is delayed by 15 minutes and provided by NYSE, NASDAQ, AMEX, and ARCX (also known as ARCA).
TradeStation pays third parties for the data and other information included on this page (the “Content”). TradeStation makes the Content available for informational purposes only. The Content should not be considered an offer or solicitation to buy or sell any investment/security. Stock prices can fluctuate wildly, and analyst ratings are provided to help self-directed traders evaluate securities. An analyst “buy” rating does not mean that a stock price will increase just as an analyst “sell” rating does not mean that a stock price will decrease.
TradeStation Securities is a member of SIPC, which protects securities customers of its members up to $500,000 (including $250,000 for claims for cash). TradeStation Securities’ SIPC coverage is available only for securities and for cash held in connection with the purchase or sale of securities, in equities and equities options accounts. Explanatory brochure available upon request or at www.sipc.org. SIPC coverage is not available for TradeStation Crypto accounts.
TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., operating under its own brand and trademarks. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means.